Conatus Pharmaceuticals CFO Susan Knudson's 2022 pay jumps 26% to $681K

Conatus Pharmaceuticals reports 2022 executive compensation

By ExecPay News

Published: May 1, 2023

Conatus Pharmaceuticals reported fiscal year 2022 executive compensation information on May 1, 2023.
In 2022, three executives at Conatus Pharmaceuticals received on average a compensation package of $508K, a 8% increase compared to previous year.
Average pay of disclosed executives at Conatus Pharmaceuticals
Susan A. Knudson, Chief Financial Officer, received $681K in total, which increased by 26% compared to 2021. 68% of Knudson's compensation, or $466K, was in salary. Knudson also received $187K in non-equity incentive plan and $28K in option awards.
Steven J. Mento, Chief Executive Officer, received a compensation package of $560K, which increased by 40% compared to previous year. 95% of the compensation package, or $532K, was in salary.
Joyce Reyes, Senior Vice President of Regulatory, Quality, Clinical Operations & Technical Operations, earned $281K in 2022.

Related executives

Steven Mento

Conatus Pharmaceuticals

Chief Executive Officer

Susan Knudson

Conatus Pharmaceuticals

Chief Financial Officer

Joyce Reyes

Conatus Pharmaceuticals

Senior Vice President of Regulatory, Quality, Clinical Operations & Technical Operations

You may also like

Source: SEC filing on May 1, 2023.